Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

Zacks #1 Stocks on the Move 05/23/2013

Company Name Symbol %Change
ALLIANCE FIB AFOP
5.21%
CYNOSURE INC CYNO
4.42%
DAWSON GEOPH DWSN
4.33%
MARRIOTT VAC VAC
3.27%
BLOOMIN' BLMN
2.93%
Zacks ZACKS.COM
PROFIT from the PROS

Tactics that Work in Good Markets and Bad
 
--

Recession Scenarios Abound

Kevin Cook here filling in for Steve this week.

The "wait 'n see" mentality is slowly settling into the market. After a mild recession has been quickly priced into stocks, this is a calmer view of the investing landscape where fear and volatility subside and institutional investors process the economic data to build new projections about how much worse it could get.

What are they waiting for? More visibility about economic growth and the impact that last month's GDP revisions will have on corporate earnings estimates. Remember, even though we are starting to get lower macro growth forecasts from the big investment research houses, we haven't even begun to see the company-specific downward earnings revisions that could come from analysts in September -- and into October earnings season.

If stocks are flirting with the "cliff", as I call the S&P 1,100 level, oil, copper, and the euro – 3 good barometers of risk appetite – are holding up well above $80, near $4, and around $1.43 respectively. Speaking of the euro, we still wait to see if the political wrangling in that monetary "dis-union" has large ripple effects that tilt the US closer to recession, especially if a banking crisis unfolds or European growth slips further than expected.

Until we know more about the economy and its vulnerabilities – and many are just waiting to see what Ben Bernanke says at Jackson Hole on Friday – stocks could easily dip below 1,100 in another wave of recession fears. But bargain hunters will be rewarded "buying the dips and selling the rips." I've called this a trader's market for the next two months where you don't need to worry about missing the bottom, and need only trade the swings when good stocks go on sale.

Featured Commentaries on Zacks.com
•  Talk About Really Cheap!
•  What Does Europe and Libya Mean for Us?
•  Just 2 Scenarios: Recession or Not

Best,

Kevin Cook
Senior Stock Strategist, Zacks Investment Research

 

Sponsor

New Report: Biotech BOOM Imminent...

A small biotech in California is about to change the course of medical history forever. The CDC calls this technology "the next evolution in medical treatments." The U.S. Health Dept. says, "We're on the cusp of a worldwide explosion" and this firm is a catalyst.

Click here to get a FREE investor report on this early opportunity.

 

Today's Top Stories: Tuesday- August 23, 2011

ZACKS RANK BUY STOCKS

Learn how to profit from our exclusive Zacks Rank stock-ranking system with free resources. Read More...

 

ZACKS MUTUAL FUND RANK

BEST OF ZACKS EQUITY RESEARCH

 

Sponsor

FINDING #1 STOCKS


In Kevin Matras' new book, Finding #1 Stocks: Screening, Backtesting and Time-Proven Strategies, he covers what you really need to know to pick better stocks, including his personal favorite trading strategies. He's giving you the most complete look at nearly market-tripling Zacks tips, techniques and strategies to help you enhance your stock gains—all in one place for the first time ever!


This is the perfect opportunity to see Zacks strategies that have never before been made public.


Learn more now>>

 

NEW ZACKS VIDEOS:

PeopleAndPicks.com:

VIP "Neurodoc" gains double digit returns with BUY calls in (QID), (STS) and (TZA). Read More...

BEST OF ZACKS.COM PARTNER COMMENTARY

FACEBOOK

Visit the Zacks.com Facebook page and get the latest insight on stocks and the market:
Zacks On Facebook

 

TWITTER

Get the Zacks.com newsfeed delivered straight to your Twitter account:
Zacks On Twitter

OTHER ZACKS RESOURCES:

 

Manage your Profit from the Pros subscription:

REFER-A-FRIEND

If you enjoy this e-mail newsletter, then please pass it along to a friend. Simply forward them the link below to sign up for their own free subscription. THANKS!
Refer a Friend

Best,

Steve Reitmeister
Executive VP, Zacks Investment Research

p.s. What is the mission for Zacks Profit from the Pros? To find out how we will help you become a more successful investor, click here.

Visit /performance for information about the performance numbers displayed in this newsletter.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

To contact us by mail:

Zacks Investment Research
Attn: Profit from the Pros
111 N. Canal St., Suite 1101
Chicago, IL 60606

To unsubscribe from receiving "Zacks.com Profit from the Pros"
e-mail newsletter, Click here....

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.